Google open-sourced Harness2, a recursive agent harnessing framework that lifted GLM-5 11.5 points on WorkBuddy-Bench with ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a ...

Recursion (RXRX) stock dips after $200M equity offering despite Sanofi (SNY) choosing its first AI drug candidate under a ...

Since I called it three times in the recursion, the return process also happens three times. Even though I understood it in ...

Recursion Pharmaceuticals (RXRX) held about $557 million in cash at the end of its second quarter of 2026. Investors should ...

Recursion Pharma launches a $200M equity offering and reports a Sanofi milestone but is rated a Hold on limited near-term ...

There has been another major milestone in the field of AI-driven drug discovery (AI drug discovery).I would like to organize ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent ...

Recursion Pharmaceuticals Inc. stocks have been trading up by 15.41 percent amid heightened optimism over its AI-driven drug ...

The phenomenon of recursive self-improvement, once considered as a figment of imagination or a distant ambition for technology researchers, is now turning into a reality as the artificial intelligence ...

Amodei’s most recent manifesto, “ We Must Pace the Frontier, ” calls precisely for tapping the brakes on A.I., “not just ...